Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., listed on Nasdaq under the ticker HSAQ, is a healthcare and life sciences focused blank-check special purpose acquisition company that completed its initial public offering in 2021. The company filed a Form 10-Q with the SEC on May 17, 2021, reflecting its active search-phase status as a blank-check entity pursuing a business combination target in the biomedical space. HSAQ subsequently announced and closed a merger with Orchestra BioMed, Inc., a cardiovascular medical device company developing bioelectronic medicine and remote monitoring therapies, bringing the combined entity to market. Readers seeking full filing histories, deal timelines, and sponsor profiles for HSAQ and the broader SPAC universe are encouraged to sign up for SpacDesk.